Recurrent Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization

The purposes of this study were to evaluate the sonographic findings of recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization and to determine how often the lesion conspicuity of the recurrent hepatocellular carcinoma makes it suitable for percutaneous sonographically guided radio frequency ablation.

[1]  Sang Woo Park,et al.  Sequential Changes in Echogenicity and Conspicuity of Small Hepatocellular Carcinoma on Gray Scale Sonography After Transcatheter Arterial Chemoembolization , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[2]  Young Jun Kim,et al.  Targeted sonography for small hepatocellular carcinoma discovered by CT or MRI: factors affecting sonographic detection. , 2010, AJR. American journal of roentgenology.

[3]  E. Hecht,et al.  Hepatocellular carcinoma: Assessment of response to transarterial chemoembolization with image subtraction , 2010, Journal of magnetic resonance imaging : JMRI.

[4]  Riccardo Lencioni,et al.  Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma , 2010, Seminars in liver disease.

[5]  C. Yoon,et al.  Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study. , 2009, Journal of vascular and interventional radiology : JVIR.

[6]  K. Togashi,et al.  Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment? , 2009, Radiology.

[7]  H. Shirato,et al.  Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma: better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection , 2009, Japanese Journal of Radiology.

[8]  W. Kwon,et al.  Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation. , 2009, The British journal of radiology.

[9]  K. Takeda,et al.  Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm. , 2009, Journal of vascular and interventional radiology : JVIR.

[10]  Masatoshi Kudo,et al.  Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. , 2008, AJR. American journal of roentgenology.

[11]  B. Daniele,et al.  Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma , 2008 .

[12]  K. Takeda,et al.  Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy. , 2008, Radiology.

[13]  Chen-Chun Lin,et al.  Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. , 2008, AJR. American journal of roentgenology.

[14]  H. Yamagata,et al.  Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system. , 2007, European journal of radiology.

[15]  G. Gandini,et al.  Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC) , 2006, European Radiology.

[16]  F. Roudot-thoraval,et al.  Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  Y. Chung.  A Strategy for Early Detection of Recurrent Hepatocellular Carcinoma following Initial Remission by Transcatheter Arterial Chemoembolization , 2005, Intervirology.

[18]  M. Kudo,et al.  Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography. , 2004, AJR. American journal of roentgenology.

[19]  J. Lee,et al.  Therapeutic Response Evaluation of Malignant Hepatic Masses Treated by Interventional Procedures With Contrast‐Enhanced Agent Detection Imaging , 2003, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[20]  K. Takeda,et al.  Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. , 2002, Journal of vascular and interventional radiology : JVIR.

[21]  John Wong,et al.  Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma , 2002, Hepatology.

[22]  K. Han,et al.  Local radiotherapy for unresectable hepatocellular carcinoma patients who failed with transcatheter arterial chemoembolization. , 2000, International journal of radiation oncology, biology, physics.

[23]  M. Al-Ahwal,et al.  Chemoembolization in hepatocellular carcinoma. , 1998, Saudi medical journal.

[24]  S. Ishiguro,et al.  Hepatocellular carcinoma: sonographic and histologic correlation. , 1983, AJR. American journal of roentgenology.

[25]  Riccardo Lencioni,et al.  Design and endpoints of clinical trials in hepatocellular carcinoma. , 2008, Journal of the National Cancer Institute.

[26]  Y. Kono,et al.  Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. , 2007, Journal of vascular and interventional radiology : JVIR.

[27]  田中 幸子.  Hepatocellular carcinoma : sonographic and histologic correlation , 1983 .